Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Preparation Methods to Measure Free Cortisol Evaluated

By LabMedica International staff writers
Posted on 04 Oct 2011
The assessment of free rather that total cortisol may be beneficial for the diagnosis of critical illness-related cortisol insufficiency.

Centrifugal ultrafiltration could provide timely free cortisol data that should correlate with the equilibrium dialysis technique when the free cortisol fractions are identically quantified by chemiluminescence immunoassay.

A prospective, multi-institutional, observational cohort investigation has been carried out involving seven pediatric intensive care units within the Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (Rockville, MD, USA). More...
Blood samples from165 critically ill children across the spectrum of illness severity were analyzed. Temperature-controlled centrifugal ultrafiltration (CUF) was conducted using YM-30 membrane fitters and compared with equilibrium dialysis, the gold standard, using the Rapid Equilibrium Dialysis Device. The cortisol assays were performed at using the VITROS ECi Immunodiagnostic System (Ortho Clinical Diagnostics, Rochester, NY, USA) using enhanced chemiluminescence detection.

The time to derive plasma free cortisol concentrations after centrifugal ultrafiltration was approximately 2 hours compared with the 24 hours after the equilibrium dialysis fractionation with chemiluminescence immunoassay. When using the CUF with a 30,000 molecular weight cutoff (Millipore, Billerica, MA, USA) the mean plasma free cortisol was 4.1 ± 6.7 µg/dL, representing an average of 15.2 ± 9.4% of total cortisol. Nearly 60% of subjects exhibited free cortisol of less than 2 μg/dL, and 30% had less than 0.8 µg/dL, which are previously suggested threshold concentrations for defining critical illness-related cortisol insufficiency. A strong correlation was demonstrated for the plasma-free cortisol concentrations when comparing CUF and the Pierce Protein Research Product's equilibrium dialysis fractionation (Thermo Fisher Scientific Inc, Rockford, IL, USA).

The authors concluded that the determination of CUF fractionated free cortisol was fast and results correlated highly with equilibrium dialysis fractionated free cortisol. Many children exhibited free cortisol of less than 2 µg/dL and 0.8 µg/dL, but did not demonstrate clinical evidence of critical illness-related cortisol insufficiency. The study ascertained that real-time free cortisol quantification, for the determination of adrenal function, is feasible to potentially help guide clinical decision making for cortisol replacement therapy in the pediatric intensive care unit. The study was published in September 2011, in Pediatric Critical Care Medicine.

Related Links:
Eunice Kennedy Shriver National Institute of Child Health
Ortho Clinical Diagnostics
Thermo Fisher Scientific



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Slide Scanner System
NanoZoomer S540MD
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.